The WHO 2008 classification of Ph-myeloproliferative disorders: Statement of the Czech MPD Working Group

Leukemia

Volumn 22, Issue 11, 2008, Pages 2118-2119

  Schwarz, J ^a   Penka, M ^b   Indrak K ^c   Pospisilova D ^c   Pytlik R ^d   Dulicek P ^e   Doubek, M ^b   Kren L ^b   Campr, V ^f  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c PALACKÝ UNIVERSITY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^f UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; JANUS KINASE 2;

ARTICLE; COLONY FORMATION; CZECH REPUBLIC; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; ERYTHROCYTOSIS; ERYTHROID CELL; FALSE NEGATIVE RESULT; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; NOMENCLATURE; POLYCYTHEMIA; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTHEMIA; THROMBOCYTOSIS; WORLD HEALTH ORGANIZATION;

EID: 56249093802     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.93     Document Type: Article

References (8)

1. Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14-22.
2. James C, Delhommeau F, Marzac C, Teyssandier I, Couédic J-P, Giraudier S et al. Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis. Leukemia 2006; 20: 350-353.
3. Marková J, Průková D, Volková Z, Schwarz J. A new allelic discrimination assay using locked nucleic acid-modified nucleotides (LNA) probes for detection of JAK2 V617F mutation. Leuk Lymphoma 2007; 48: 636-639.
4. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007; 356: 459-468.
5. 9/I be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages. Br J Haematol 1998; 100 15-23.
6. Michiels JJ, Thiele J. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia). Int J Hematol 2002; 76: 133-145.
7. Schwarz J, Pytlík R, Doubek M, Brychtová Y, Dulíćek P, Campr V et al. Analysis of risk factors: The rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with thrombocythemia. Semin Thromb Hemost 2006; 32: 231-245.
8. Thiele J, Kvasnicka HM, Orazi A. Bone marrow histopathology in myeloproliferative disorders - current diagnostic approach. Semin Hematol 2005; 42: 184-195.